HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)
Journal article

HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)

  • Diehl, V. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Brillant, C. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Engert, A. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Mueller, R. P. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Mueller-Hermelink, H. K. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Hermann, R. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Doerken, B. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Kanz, L. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Greil, R. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
  • Pfistner, B. Univ Hosp of Cologne, Cologne, Germany; Univ Wuerzburg, Wuerzburg, Germany; Kantonsspital, Basel, Switzerland; Campus Virchow Klin, Berlin, Germany; Eberhard-Karls-University, Tübingen, Germany; Univ of Innsbruck, Innsbruck, Austria
Show more…
Published in:
  • Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2005, vol. 23, no. 16_suppl, p. 6506-6506
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/170903
Statistics

Document views: 39 File downloads: